New tumor markers: CA125 and beyond

This publication has 43 references indexed in Scilit:

• Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
  Clinical Cancer Research, 2005
• Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples
  Gynecologic Oncology, 2004
• Mechanisms of Taxol resistance related to microtubules
  Oncogene, 2003
• TP53 and ovarian cancer
  Human Mutation, 2003
• Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation
  Oncology Research, 2003
• Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers
  Seminars in Oncology, 2001
• Molecular Cloning of the CA125 Ovarian Cancer Antigen
  Journal of Biological Chemistry, 2001
• The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer
  Gynecologic Oncology, 2000
• The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction
  American Journal of Obstetrics and Gynecology, 1990
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990